Larimar Therapeutics (LRMR) Preferred Dividend Payments (2013 - 2014)
Larimar Therapeutics (LRMR) posted Preferred Dividend Payments of $43000.0 for Q2 2014, down 12.24% on a QoQ basis from $49000.0 in Q1 2014, and down 20.37% year-over-year from $54000.0 in Q2 2013.
Larimar Therapeutics (LRMR) Preferred Dividend Payments (2013 - 2014) Analysis & Trends
Larimar Therapeutics' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $43000.0 for Q2 2014.
- Quarterly Preferred Dividend Payments fell 20.37% year-over-year to $43000.0 in Q2 2014, while the trailing twelve-month figure through Dec 2014 was $92000.0 (changed N/A YoY) and the FY2014 annual result came in at $92000.0, down 56.81% from the prior year.
- Preferred Dividend Payments was $43000.0 for Q2 2014 at Larimar Therapeutics, down from $49000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $54000.0 in Q2 2013 and bottomed at $43000.0 in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 43,000.00 |
| Mar 31, 2014 | 49,000.00 |
| Dec 31, 2013 | 53,000.00 |
| Sep 30, 2013 | 53,000.00 |
| Jun 30, 2013 | 54,000.00 |